The global Age Related Macular Degeneration Drug market was valued at 7124.63 Million USD in 2020 and will grow with a CAGR of 6.01% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for "straight-ahead" activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.Age Related Macular Degeneration Drug is widely used in hospitals, clinics and other field. The most proportion of Age Related Macular Degeneration Drug is used in Hospital, and the proportion in 2017 is 72%. North America is the largest consumption place, with a consumption market share nearly 65.6% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
By Market Verdors:
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
By Types:
Lucentis
Eylea
Avastin
By Applications:
Hospitals
Clinics
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Age Related Macular Degeneration Drug Market Size Analysis from 2022 to 2027
1.5.1 Global Age Related Macular Degeneration Drug Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Age Related Macular Degeneration Drug Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Age Related Macular Degeneration Drug Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Age Related Macular Degeneration Drug Industry Impact
Chapter 2 Global Age Related Macular Degeneration Drug Competition by Types, Applications, and Top Regions and Countries
2.1 Global Age Related Macular Degeneration Drug (Volume and Value) by Type
2.1.1 Global Age Related Macular Degeneration Drug Consumption and Market Share by Type (2016-2021)
2.1.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2016-2021)
2.2 Global Age Related Macular Degeneration Drug (Volume and Value) by Application
2.2.1 Global Age Related Macular Degeneration Drug Consumption and Market Share by Application (2016-2021)
2.2.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Application (2016-2021)
2.3 Global Age Related Macular Degeneration Drug (Volume and Value) by Regions
2.3.1 Global Age Related Macular Degeneration Drug Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Age Related Macular Degeneration Drug Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Age Related Macular Degeneration Drug Consumption by Regions (2016-2021)
4.2 North America Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
4.10 South America Age Related Macular Degeneration Drug Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Age Related Macular Degeneration Drug Market Analysis
5.1 North America Age Related Macular Degeneration Drug Consumption and Value Analysis
5.1.1 North America Age Related Macular Degeneration Drug Market Under COVID-19
5.2 North America Age Related Macular Degeneration Drug Consumption Volume by Types
5.3 North America Age Related Macular Degeneration Drug Consumption Structure by Application
5.4 North America Age Related Macular Degeneration Drug Consumption by Top Countries
5.4.1 United States Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
5.4.2 Canada Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
5.4.3 Mexico Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 6 East Asia Age Related Macular Degeneration Drug Market Analysis
6.1 East Asia Age Related Macular Degeneration Drug Consumption and Value Analysis
6.1.1 East Asia Age Related Macular Degeneration Drug Market Under COVID-19
6.2 East Asia Age Related Macular Degeneration Drug Consumption Volume by Types
6.3 East Asia Age Related Macular Degeneration Drug Consumption Structure by Application
6.4 East Asia Age Related Macular Degeneration Drug Consumption by Top Countries
6.4.1 China Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
6.4.2 Japan Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
6.4.3 South Korea Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 7 Europe Age Related Macular Degeneration Drug Market Analysis
7.1 Europe Age Related Macular Degeneration Drug Consumption and Value Analysis
7.1.1 Europe Age Related Macular Degeneration Drug Market Under COVID-19
7.2 Europe Age Related Macular Degeneration Drug Consumption Volume by Types
7.3 Europe Age Related Macular Degeneration Drug Consumption Structure by Application
7.4 Europe Age Related Macular Degeneration Drug Consumption by Top Countries
7.4.1 Germany Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
7.4.2 UK Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
7.4.3 France Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
7.4.4 Italy Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
7.4.5 Russia Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
7.4.6 Spain Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
7.4.7 Netherlands Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
7.4.8 Switzerland Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
7.4.9 Poland Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 8 South Asia Age Related Macular Degeneration Drug Market Analysis
8.1 South Asia Age Related Macular Degeneration Drug Consumption and Value Analysis
8.1.1 South Asia Age Related Macular Degeneration Drug Market Under COVID-19
8.2 South Asia Age Related Macular Degeneration Drug Consumption Volume by Types
8.3 South Asia Age Related Macular Degeneration Drug Consumption Structure by Application
8.4 South Asia Age Related Macular Degeneration Drug Consumption by Top Countries
8.4.1 India Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
8.4.2 Pakistan Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Age Related Macular Degeneration Drug Market Analysis
9.1 Southeast Asia Age Related Macular Degeneration Drug Consumption and Value Analysis
9.1.1 Southeast Asia Age Related Macular Degeneration Drug Market Under COVID-19
9.2 Southeast Asia Age Related Macular Degeneration Drug Consumption Volume by Types
9.3 Southeast Asia Age Related Macular Degeneration Drug Consumption Structure by Application
9.4 Southeast Asia Age Related Macular Degeneration Drug Consumption by Top Countries
9.4.1 Indonesia Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
9.4.2 Thailand Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
9.4.3 Singapore Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
9.4.4 Malaysia Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
9.4.5 Philippines Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
9.4.6 Vietnam Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
9.4.7 Myanmar Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 10 Middle East Age Related Macular Degeneration Drug Market Analysis
10.1 Middle East Age Related Macular Degeneration Drug Consumption and Value Analysis
10.1.1 Middle East Age Related Macular Degeneration Drug Market Under COVID-19
10.2 Middle East Age Related Macular Degeneration Drug Consumption Volume by Types
10.3 Middle East Age Related Macular Degeneration Drug Consumption Structure by Application
10.4 Middle East Age Related Macular Degeneration Drug Consumption by Top Countries
10.4.1 Turkey Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
10.4.3 Iran Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
10.4.5 Israel Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
10.4.6 Iraq Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
10.4.7 Qatar Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
10.4.8 Kuwait Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
10.4.9 Oman Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 11 Africa Age Related Macular Degeneration Drug Market Analysis
11.1 Africa Age Related Macular Degeneration Drug Consumption and Value Analysis
11.1.1 Africa Age Related Macular Degeneration Drug Market Under COVID-19
11.2 Africa Age Related Macular Degeneration Drug Consumption Volume by Types
11.3 Africa Age Related Macular Degeneration Drug Consumption Structure by Application
11.4 Africa Age Related Macular Degeneration Drug Consumption by Top Countries
11.4.1 Nigeria Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
11.4.2 South Africa Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
11.4.3 Egypt Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
11.4.4 Algeria Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
11.4.5 Morocco Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 12 Oceania Age Related Macular Degeneration Drug Market Analysis
12.1 Oceania Age Related Macular Degeneration Drug Consumption and Value Analysis
12.2 Oceania Age Related Macular Degeneration Drug Consumption Volume by Types
12.3 Oceania Age Related Macular Degeneration Drug Consumption Structure by Application
12.4 Oceania Age Related Macular Degeneration Drug Consumption by Top Countries
12.4.1 Australia Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
12.4.2 New Zealand Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 13 South America Age Related Macular Degeneration Drug Market Analysis
13.1 South America Age Related Macular Degeneration Drug Consumption and Value Analysis
13.1.1 South America Age Related Macular Degeneration Drug Market Under COVID-19
13.2 South America Age Related Macular Degeneration Drug Consumption Volume by Types
13.3 South America Age Related Macular Degeneration Drug Consumption Structure by Application
13.4 South America Age Related Macular Degeneration Drug Consumption Volume by Major Countries
13.4.1 Brazil Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
13.4.2 Argentina Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
13.4.3 Columbia Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
13.4.4 Chile Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
13.4.5 Venezuela Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
13.4.6 Peru Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
13.4.8 Ecuador Age Related Macular Degeneration Drug Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Age Related Macular Degeneration Drug Business
14.1 Regeneron Pharmaceuticals
14.1.1 Regeneron Pharmaceuticals Company Profile
14.1.2 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Specification
14.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Bayer HealthCare
14.2.1 Bayer HealthCare Company Profile
14.2.2 Bayer HealthCare Age Related Macular Degeneration Drug Product Specification
14.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Novartis
14.3.1 Novartis Company Profile
14.3.2 Novartis Age Related Macular Degeneration Drug Product Specification
14.3.3 Novartis Age Related Macular Degeneration Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Roche
14.4.1 Roche Company Profile
14.4.2 Roche Age Related Macular Degeneration Drug Product Specification
14.4.3 Roche Age Related Macular Degeneration Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Kanghong Pharma
14.5.1 Kanghong Pharma Company Profile
14.5.2 Kanghong Pharma Age Related Macular Degeneration Drug Product Specification
14.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Age Related Macular Degeneration Drug Market Forecast (2022-2027)
15.1 Global Age Related Macular Degeneration Drug Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Age Related Macular Degeneration Drug Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Age Related Macular Degeneration Drug Value and Growth Rate Forecast (2022-2027)
15.2 Global Age Related Macular Degeneration Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Age Related Macular Degeneration Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Age Related Macular Degeneration Drug Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Age Related Macular Degeneration Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Age Related Macular Degeneration Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Age Related Macular Degeneration Drug Consumption Forecast by Type (2022-2027)
15.3.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2022-2027)
15.3.3 Global Age Related Macular Degeneration Drug Price Forecast by Type (2022-2027)
15.4 Global Age Related Macular Degeneration Drug Consumption Volume Forecast by Application (2022-2027)
15.5 Age Related Macular Degeneration Drug Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
The Flying Car Electric Drive Housing Related Parts Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitiv...
The Drug Temperature Monitoring System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Small Molecule Drug CDMO Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Executive Summary
Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...
Executive Summary
Azoth Analytics has released a research report titled "Global Irritable Bowel Disease Market (2024 Edition)" which provides a complete analysis of the Global Irritable Bowel Disease industry in terms of market segmentation By Drug Class (Corticosteroids, JAK inhibitors...
The Intelligent Drug Delivery Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
The Contract Drug Discovery Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Computer-assisted Drug Design Platform Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsca...
Executive Summary
Azoth Analytics has released a research report titled "Global Therapeutic Antibody Market (2023 Edition)" which provides a complete analysis of the Global Therapeutic Antibody industry in terms of market segmentation By Product Type (Monoclonal Antibody, Bispecific Ant...
Executive Summary
Azoth Analytics has released a research report titled "Global Cephalosporin Drug Market (2024 Edition)" which provides a complete analysis of the Global Cephalosporin Drug industry in terms of market segmentation By Generation (First Generation, Second Generation, Thir...